About Discovery Genomics
Discovery Genomics is a company based in Minneapolis (United States) founded in 2000 was acquired by Immusoft in March 2016. Discovery Genomics has raised $4 million across 3 funding rounds from investors including Immusoft, Bio-Techne and HHS. Discovery Genomics offers products and services including Quote Comparison Service. Discovery Genomics operates in a competitive market with competitors including Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.
- Headquarter Minneapolis, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Discovery Genomics
Discovery Genomics offers a comprehensive portfolio of products and services, including Quote Comparison Service.
Online tool for comparing Medicare plans and getting quotes
Funding Insights of Discovery Genomics
Discovery Genomics has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.77 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Discovery Genomics
Discovery Genomics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Immusoft, Bio-Techne and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of biotech reagents, instruments and clinical diagnostic products
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
B cells are programmed as biofactories for therapeutic protein delivery.
|
Locked | Locked | Locked |
Investor details for Discovery Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Discovery Genomics
Investment portfolio details for Discovery Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Discovery Genomics
Detailed financials for Discovery Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Discovery Genomics Comparisons
Peer comparison for Discovery Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Discovery Genomics
Discovery Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
Detailed competitors of Discovery Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Discovery Genomics
Complete news archive for Discovery Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Discovery Genomics
Discovery Genomics was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Discovery Genomics is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Discovery Genomics is a funded company, having raised a total of $4M across 3 funding rounds to date.
Discovery Genomics, a functional genomics company created to discover gene functions, conduct drug target validations, and design therapeutic agents based on genomics information. The company holds exclusive licenses from the University of Minnesota to develop technologies related to knock-downs in Zebrafish using a proprietary Morphant(TM) technology and to the use of the Sleeping Beauty Transposon(TM). Both technologies may be used for functional genomics and the discovery of drug targets. The transposon may have applications in gene therapy. Morphant(TM) knock-downs are used to suppress and thereby study the functions of particular genes.
Discovery Genomics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Discovery Genomics offers Quote Comparison Service.
Discovery Genomics has 3 investors. Key investors include Immusoft, Bio-Techne, and HHS.